Improvement of some pharmaceutical properties of mycophenolate mofetil (MMF) by para sulphonatocalix[4]resorcinarene inclusion complex
| 详细信息 | 推荐本文 | |
- 作者：Shobhana K. Menon (1) shobhanamenon07@gmail.com
Nishith R. Modi (1)
Bhoomika Mistry (1)
Kuldeep Joshi (1) - 关键词：Para sulphonatocalix[4]resorcinarene – ; MMF – ; Phase solubility study – ; In vitro release – ; Acute toxicity – ; Inclusion complex
- 刊名：Journal of Inclusion Phenomena and Macrocyclic Chemistry
- 出版时间：June 2011
- 出版年：2011
- 期刊代码：19_09230750
- 类别：soc
- 卷：70
- 期：1-2
- 页码：121-128
- 数据来源：sp
摘要
As a part of our investigations to unfold the chemistry of calixresorcinarene, we have focused on the formation of inclusion complex of a poorly soluble (43 μg ml−1 at pH 7) drug mycophenolate mofetil (MMF) an immunosuppressive agent and an inosine monophosphate dehydrogenase (IMPDH) inhibitor with para sulphonatocalix[4]resorcinarene (PSC4R). The complete complexation of the drug was achieved after 48 h of stirring with para sulphonatocalix[4]resorcinarene(PSC[4]R) in water and evaporation of water yield the solid complex. The interaction between para sulphonatocalix[4]resorcinarene(PSC[4]R) and MMF in solid state inclusion complexes was accomplished by aqueous phase solubility studies, Thermal Analysis, HPLC, PXRD, FT-IR, and UV–Vis spectroscopy. The results of the phase solubility experiments are in good conformity to signify the formation of 2:1 PSC4R: MMF complexes. The purpose of this study was to enhance solubility and resulting in high dissolution rate and bioavailability of this essentially water insoluble drug. The results of the in vivo study shows that there is a remarkable change in the toxicity of the pure drug MMF and complex did not produce any mortality up to 2200 mg kg−1.